H2AX and central nervous system cancer: Here, we found that treatment of glioma cells with axitinib triggers the DDR, evidenced by increased levels of phosphorylated H2AX and Ser345-Chk1, leading to cell cycle arrest at G2/M phase and accumulation of polyploid glioma cells undergoing mitotic catastrophe.